Carbapenem-resistance oprD mutations reshape Pseudomonas aeruginosa host-pathogen interactions during infection
Open Access
- 10 April 2026
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Abstract
Antibiotic resistance is a major global health threat. While its role in reducing drug susceptibility is well established, the broader consequences of resistance mutations on bacterial physiology and phenotype during infection remain poorly understood. Carbapenem-resistant Pseudomonas aeruginosa is considered among the highest-priority bacterial threats, with resistance commonly driven by loss-of-function mutations in the carbapenem uptake porin OprD. Here we show that such mutations can arise in clinical isolates even without prior carbapenem treatment, suggesting that their biological impact during infection is not limited to antibiotic resistance. Consistent with this, we found that oprD mutants exhibit enhanced early attachment to and translocation across airway epithelial barriers in an in vitro human infection model, an effect observed across strains with distinct clinical genomic backgrounds and infection dynamics. Our findings indicate that loss of OprD alters the bacterial outer membrane charge and reduces mucus entrapment, thereby facilitating epithelial barrier colonization. Overall, these results illustrate how antibiotic resistance mutations can directly shape infection dynamics, extending their impact well beyond antimicrobial susceptibility.Keywords
This publication has 49 references indexed in Scilit:
- Cell-type-independent infection dynamics of clinical Pseudomonas aeruginosa isolates in human airway epithelial modelsCell Reports, 2026
- Pseudomonas infections persisting after CFTR modulators are widespread throughout the lungs and drive lung inflammationCell Host & Microbe, 2025
- Pseudomonas aeruginosa: persistence beyond antibiotic resistanceTrends in Microbiology, 2025
- The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistanceThe Lancet Infectious Diseases, 2025
- Multidrug-resistant Gram-negative bacterial infectionsThe Lancet, 2025
- Role of bacterial multidrug efflux pumps during infectionWorld Journal of Microbiology and Biotechnology, 2024
- Antibiotic Resistance in Pseudomonas2022
- Global burden of bacterial antimicrobial resistance in 2019: a systematic analysisThe Lancet, 2022
- Pseudomonas aeruginosa: an antibiotic resilient pathogen with environmental originCurrent Opinion in Microbiology, 2021
- Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogenNature, 2000